1Wollert KC,Rolsnd S,Bodil BS. Survival after myocardial infarction in the rat:role of tissue angiotensin converting enzyme inhibition[ J ]. Circulation, 1994,90(5) :2457-2467.
2Davidson NC, Wendy JC, David JW. Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor in patients with chronic heart failure[J]. Heart,1996,75(6) :576-581.
3Dirk J, Veldhuisen V, Sabine GZ. High-versus low-dose ACE inhibitor in chronic heart failure : a double-blind, placebo-controlled study of imidspril[ J ]. J Am Coll Cardiol, 1998,32 (7) : 1811-1818
4Cleland J,Semple P, Hodsman P. Angiotensin levels, hemodynamics and sympathoadrenal function after low-dose captopril in heart failure[ J ]. Am J Med,1984,77(5) :880-886.
5Rocca HP,Weilenmann D, Kiowski W. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormonal levels in patients with chronic heart failure[J]. Am Heart J,1999,138(4 pt 1 ) :654-662.
6Pacher R, Glibits S, Bergler J. Clinical sad neurohumoral response of patients with severe congestive heart failure treated with two different captopril desages[J]. Eur Heart J, 1993,14(2) :273-278.
7Pellenc PM, Rudnicki A, Leclereq P. Enaiapril in the treatment of mild to moderate heart failure in general medical practive:a prospective and multicenters study concerning 17 546 patients[ J ]. Acta Cardiol, 1995,50 ( 3 ) ; 187 -201.
8Quinapril Research Group. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure[J]. Eur Hem J,1991,12(6) :705-711.
9Testa M, Yeh g, Lee P. Cireulating levels of cytokines and the endogenous modulators in patients with mild to severe congestive heart failure due to coroanry artery disease or hypertension[J]. J Am Coll Cardiol,1996,28(4) :964-971.
10Gullestad L, Aukrust P, Ueland T. Effects of hish-versus low-dose angiotensin converting enzyme inhibitor on cytokine levels in chronic heart failure [ J ]. J Am Coll Cardiol,1999,34(7) :2061-2067.
8Denis L,Clemem T,Tomas M.Long-term effects of clinical outcome with low and high dose in the captopril in heart insufficient patients study.Acta Cardiol,2000,55(1): 1～7.
9Mccullough PA, Omland T, Maisel AS. Btype natriuretic peptides : a diagnositic breakthrough for clinicians. Rev Cardiovasc Med ,2003, 4(2) :72-80.
10Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol, 2001,21 (6) :661-672.
